Targeted de-escalation rounds may effectively and safely reduce meropenem use

Targeted de-escalation rounds may effectively and safely reduce meropenem use Ir J Med Sci (2017) 186:729–732 DOI 10.1007/s11845-016-1504-9 ORIGINAL ARTICLE Targeted de-escalation rounds may effectively and safely reduce meropenem use 1 2 3 4 3 • • • • • U. Ni Riain M. Tierney C. Doyle A. Vellinga C. Fleming M. Cormican Received: 10 June 2016 / Accepted: 17 September 2016 / Published online: 29 September 2016 Royal Academy of Medicine in Ireland 2016 Abstract The median days of meropenem use in patients where Objective Use of meropenem in our hospital has doubled meropenem was de-escalated was 4.5 days (range 2–19) in recent years. An audit in 2013 showed that although compared with 14 days (range 6–84) where de-escalation initiation of therapy with meropenem was generally was not recommended or the recommendation was not appropriate, therapy was rarely subsequently reviewed and implemented. There was no statistically significant differ- de-escalated where appropriate. Therefore, a structured ence in crude mortality between patients de-escalated from stewardship initiative focussed on meropenem de-escala- meropenem and those where meropenem was continued. tion was developed. Conclusion This pilot study suggests that targeted car- Methods A local guideline for review and de-escalation of bapenem de-escalation stewardship activity based on pre- meropenem was developed and approved by http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Irish Journal of Medical Science (1971 -) Springer Journals

Targeted de-escalation rounds may effectively and safely reduce meropenem use

Loading next page...
 
/lp/springer_journal/targeted-de-escalation-rounds-may-effectively-and-safely-reduce-jTCZKseBev
Publisher
Springer London
Copyright
Copyright © 2016 by Royal Academy of Medicine in Ireland
Subject
Medicine & Public Health; Internal Medicine; General Practice / Family Medicine
ISSN
0021-1265
eISSN
1863-4362
D.O.I.
10.1007/s11845-016-1504-9
Publisher site
See Article on Publisher Site

Abstract

Ir J Med Sci (2017) 186:729–732 DOI 10.1007/s11845-016-1504-9 ORIGINAL ARTICLE Targeted de-escalation rounds may effectively and safely reduce meropenem use 1 2 3 4 3 • • • • • U. Ni Riain M. Tierney C. Doyle A. Vellinga C. Fleming M. Cormican Received: 10 June 2016 / Accepted: 17 September 2016 / Published online: 29 September 2016 Royal Academy of Medicine in Ireland 2016 Abstract The median days of meropenem use in patients where Objective Use of meropenem in our hospital has doubled meropenem was de-escalated was 4.5 days (range 2–19) in recent years. An audit in 2013 showed that although compared with 14 days (range 6–84) where de-escalation initiation of therapy with meropenem was generally was not recommended or the recommendation was not appropriate, therapy was rarely subsequently reviewed and implemented. There was no statistically significant differ- de-escalated where appropriate. Therefore, a structured ence in crude mortality between patients de-escalated from stewardship initiative focussed on meropenem de-escala- meropenem and those where meropenem was continued. tion was developed. Conclusion This pilot study suggests that targeted car- Methods A local guideline for review and de-escalation of bapenem de-escalation stewardship activity based on pre- meropenem was developed and approved by

Journal

Irish Journal of Medical Science (1971 -)Springer Journals

Published: Sep 29, 2016

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off